Neonutra   Report issue

For profit
Founded: Seoul Korea, Republic of (2005)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2017
NCT03757611
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Neonutra

Active Ingredients

Drugs in Other Trials (1)

taheebo (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1